同和药业：公司原料药通过CDE审批

Core Viewpoint - The company has received approval from the National Medical Products Administration (NMPA) for its active pharmaceutical ingredient, tolvaptan, which is now registered for use in formulations [1] Group 1: Approval Details - The active pharmaceutical ingredient "Tolvaptan" has been approved by the NMPA [1] - The registration number for the product is Y20240000672 [1] - The product is manufactured domestically by Jiangxi Tonghe Pharmaceutical Co., Ltd [1] Group 2: Product Information - The product name is tolvaptan, which is intended for use in approved formulations [1] - The approval rating from the review process is A, indicating it is approved for use in marketed formulations [1]